MOLLY COX: Open Payments
NPI 1780141861 · NEW CASTLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 10 payments from 6 companies in 2025. Trend: 2023 $73 · 2024 $101 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $58 |
| Lilly USA, LLC | 2 | $45 |
| ABBVIE INC. | 2 | $38 |
| Smith+Nephew, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: Ozempic, VRAYLAR, JARDIANCE, PICO, CAPLYTA, Auvelity, MOUNJARO.
Industry payments across IN — which companies pay providers there.
